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Revisiting concepts of evidence
in implementation science
Ross C. Brownson1,2* , Rachel C. Shelton3, Elvin H. Geng4 and Russell E. Glasgow5

Abstract
Background: Evidence, in multiple forms, is a foundation of implementation science. For public health and clinical
practice, evidence includes the following: type 1 evidence on etiology and burden; type 2 evidence on effectiveness
of interventions; and type 3: evidence on dissemination and implementation (D&I) within context. To support a vision
for development and use of evidence in D&I science that is more comprehensive and equitable (particularly for type 3
evidence), this article aims to clarify concepts of evidence, summarize ongoing debates about evidence, and provide
a set of recommendations and tools/resources for addressing the “how-to” in filling evidence gaps most critical to
advancing implementation science.
Main text: Because current conceptualizations of evidence have been relatively narrow and insufficiently characterized in our opinion, we identify and discuss challenges and debates about the uses, usefulness, and gaps in evidence
for implementation science. A set of questions is proposed to assist in determining when evidence is sufficient for dissemination and implementation. Intersecting gaps include the need to (1) reconsider how the evidence base is determined, (2) improve understanding of contextual effects on implementation, (3) sharpen the focus on health equity
in how we approach and build the evidence-base, (4) conduct more policy implementation research and evaluation,
and (5) learn from audience and stakeholder perspectives. We offer 15 recommendations to assist in filling these gaps
and describe a set of tools for enhancing the evidence most needed in implementation science.
Conclusions: To address our recommendations, we see capacity as a necessary ingredient to shift the field’s
approach to evidence. Capacity includes the “push” for implementation science where researchers are trained to
develop and evaluate evidence which should be useful and feasible for implementers and reflect community or
stakeholder priorities. Equally important, there has been inadequate training and too little emphasis on the “pull” for
implementation science (e.g., training implementers, practice-based research). We suggest that funders and reviewers of research should adopt and support a more robust definition of evidence. By critically examining the evolving
nature of evidence, implementation science can better fulfill its vision of facilitating widespread and equitable adoption, delivery, and sustainment of scientific advances.
Keywords: Context, Equity, Evidence, Implementation science
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For every complex problem, there is a solution that is
simple, neat, and wrong. — H. L. Mencken

Contributions to the literature
• Evidence in multiple forms is a foundation of implementation science. We describe multiple types of evidence including evidence on etiology and burden,
effectiveness of interventions, and implementation
within context.
• We highlight what is missing in current literature on
evidence and what is needed to more fully capture and
characterize key evidence needed for dissemination
and implementation research.
• For all types of evidence and particularly for evidence
regarding dissemination and implementation, complexity and context are essential elements. We provide
15 specific recommendations to advance, specify, and
broaden the field’s conceptualization and development
of evidence.
• To fill the evidence gaps, we provide a set of tools
and resources that begin to map out the “how-to” for
accomplishing research needed to inform more equitable and sustained implementation.

Introduction
Evidence, often informed by a complex cycle of observation, theory, and experiment [1], is a foundation of
implementation science [2, 3]. Evidence is central in
part because dissemination and implementation (D&I)
science is based on the notion that there are practices
and policies that should be widely used because scientific research concludes that they would have widespread benefits. In this context, an evidence-based
intervention (EBI) is defined broadly to include programs, practices, processes, policies, and guidelines
with some level of effectiveness [4]. Many of the underlying sources of evidence were originally derived from
legal settings, taking on multiple forms including witness accounts, police testimony, expert opinions, and
forensic science [5]. Building on these origins, evidence for public health and clinical practice comes in
many forms, across three broad domains [6–8]: type
1: evidence on etiology and burden; type 2: evidence
on effectiveness of interventions; type 3: evidence on
implementation within context (Table 1). These three
types of evidence are often not linear, but interconnected, iterative, and overlapping—they shape one
another (e.g., if we have limited type 2 evidence then
the ability to apply type 3 evidence is hampered).
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Across these three domains, we have by far the most
type 1 evidence and the least type 3 evidence [6, 9].
Definitions of evidence and the associated processes
(how evidence is used) vary by setting. In clinical settings, evidence-based medicine is “the conscientious,
explicit, and judicious use of current best evidence in
making decisions about the care of individual patients”
[10]. Evidence-based public health occurs across a range
of community settings and is “the process of integrating
science-based interventions with community preferences
to improve the health of populations” [11]. Perhaps most
relevant to implementation science, evidence-based decision-making is a multilevel process that involves collecting and implementing the best available evidence from
research, practice, professional experience, and clinical
or community partners [12–15]. A robust, equitable, and
sustainable approach to evidence-based decision-making
takes both challenges and strengths into account (e.g.,
skills, leadership priorities, resources [16–19]) and places
scientific evidence and stakeholder engagement in the
center of the decision-making process [20].
For all types of evidence and particularly for type 3 evidence regarding D&I, complexity and context are essential elements [21–23]. Both PCORI [24, 25] and a recent
update to the MRC guidance [26] have provided statements about researching complex health interventions
that provide excellent recommendations and resources.
We concur with most of these recommendations and add
to their points and recommendations in this article. The
most effective approaches often rely on complex interventions embedded in complex systems (e.g., nonlinear,
multilevel interventions) where the description of core
intervention components and their relationships involve
multiple settings, audiences, and approaches [26–28].
Type 3 evidence is also highly context-dependent—the
context for implementation involves complex adaptive
systems that form the dynamic environment(s) in which
discrete interventions and interconnected implementation processes are situated [29]. For example, in models
such as the Dynamic Sustainability Framework, the EBI
is embedded in the context of multiple factors in a practice setting (e.g., staffing, organizational climate) which is
in turn embedded in a broader ecological system with a
complex set of variables (e.g., policy, regulations, population characteristics) [30]. This embeddedness also should
take into account dynamism—that an EBI may stay true
to its original function but need to evolve form over time
to adapt to changing population needs, new evidence,
and the “fit” of evidence with complex and changing context [30–32].
Much has been written about the terminology of evidence-based practice and policy. The most widely used

A particular type of health difference that is closely
linked with economic, social, or environmental
disadvantage
The study of the causes of diseases

Disparity

Etiology

The study of the structure, processes, and organization of healthcare services
A standardized set of information based on scientific evidence of the effectiveness and efficiency
of the best practices for addressing health issues
commonly encountered in public health or clinical
practice.
The comparative analysis of alternative courses of
action in terms of both their costs and consequence (e.g., cost-effectiveness analysis)

Practice guidelines

Economic evaluation

Activities designed to assess, improve, maintain,
promote, or modify health, health behaviors, functioning, or health conditions

Effectiveness of healthcare

Type 2 evidence: Effectiveness of interventions Effectiveness of interventions (programs,
guidelines, and policies)

Social determinants and structural factors Conditions in which people are born, grow, live,
work, and age as well as the complex, interrelated
social structures, and economic/political systems
that shape these health outcomes and conditions

The impact of disease on a population
The ability to connect patients to healthcare practitioners and healthcare services

Burden
Access

Intervention and implementation strategy costs,
cost-effectiveness ratio, return on investment, budget
impact analyses, opportunity and replication costs

Recommendation (e.g., recommended, not recommended, insufficient evidence), applicability across
populations and settings

Performance, quality, effectiveness, efficiency, patient
centeredness, equity, safety

Effect sizes and other indicators of effect (including
heterogeneity of results)

Effect sizes and other indicators of effect

Effect sizes and other indicators of effect

Incidence, prevalence mortality

Incidence of preventable diseases, early detection,
treatment

Excess risk in patients, populations, subgroups, costs

The study of the occurrence of disease or other
Incidence, prevalence mortality
health-related characteristics in human populations, often classified under the headings of person,
place, and time.

Descriptive epidemiology

Sample indicators and outcomes

Type 1 evidence: Etiology and burden

Definition

Element

Type

Table 1 Selected terminology related to evidence and implementation science
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Element

Sample indicators and outcomes

The process or event through which an implementation strategy operates to affect desired implementation outcomes
The degree to which explicit attention is paid to the
culture, history, values, and needs of the community during implementation, including any social
and structural factors that may contribute to health
inequities and equitable or inequitable implementation

Fit with recipients, reach, data, resources, capacity,
The degree to which an evidence-based intersatisfaction, engagement
vention is changed or modified by a user before,
during, and after adoption and implementation to
(a) suit the needs of the setting/local conditions; (b)
respond to emerging evidence; or (c) respond to
changing context
The ability to transfer an evidence-based intervention to a new setting, balancing fidelity with
adaptation
The ability to expand the coverage of successful
interventions, including the financial, human, and
capital resources necessary for the expansion
The ability to create structures and processes to
allow an implemented EBI to be maintained and
adapted in an organization or system and continue
to produce benefits over time

Implementation mechanism

Equity in implementation

Adaptation

Replication and transportability

Scale-up

Sustainability

Penetration, institutionalization, normalization, integration, capacity, infrastructure, costs, maintenance
of EBI/strategy delivery, and/or continuation of health
benefits

Usability, utility, feasibility, fidelity, adoption

Acceptability, adoption, appropriateness, cost, feasibility, cost, penetration

Inequities or differences across settings or populations in acceptability, adoption, appropriateness, cost,
feasibility, reach, implementation delivery/fidelity,
penetration, sustainability; social determinants (e.g.,
living conditions, socioeconomic indicators) unintended consequences related to implementation

Acceptability, adoption, appropriateness, cost, feasibility, cost, penetration, sustainability

Acceptability, adoption, appropriateness, cost, feasibility, cost, penetration, sustainability

The processes or methods, techniques, activities,
and resources that support the adoption, integration, and sustainment of evidence-based interventions into usual settings (e.g., ERIC taxonomy)

Implementation strategy

Staff participation, setting participation, representativeness by geography and population, cost

The extent to which inferences reported in one
study can be applied to different populations, setting, treatments, and outcomes

A set of circumstances or unique factors related to Policies, regulations, incentives, changes in priorities,
the setting or community that surround a particular setting factors, organizational characteristics, history,
implementation effort
social, and environmental factors

Definition

External validity

Type 3 evidence: Implementation and context Context

Type

Table 1 (continued)
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term is “evidence-based” practice (often evidence-based
medicine [33, 34] or evidence-based public health [7,
35]). Especially in Canada and Australia, the term “evidence-informed” decision-making is commonly used
[15, 36]. The term “informed” is used to emphasize that
public health decisions are based on research but also
require consideration of individual preferences and
political and organizational factors [37, 38]. Others have
used the term “knowledge-based practice” or “practice-based evidence” or “practice-relevant evidence”
to emphasize the importance of practice wisdom from
frontline practitioners and lived experience of patients
and community members [39–43]. To maximize the
use of EBIs, research should inform practice and practice should inform research [44]. In our view, the most
important issue is not which term to use, but rather
that implementation decisions should be based on and
informed by evaluation and research findings, while
using rigorous methods to take into account a variety of
contextual variables across multiple levels of influence
(Table 2).
Fundamental issues for implementation science
involve the questions: (1) evidence on what and for
whom in what settings and under what conditions? and
(2) When do we have enough evidence for D&I? While
the answer to this latter question will always be “it
depends,” there are related questions that are useful to
consider (Table 3).
To facilitate the development and delivery of more
equitable and sustainable interventions, we need to
expand our thinking about evidence, especially for
but not limited to type 3 evidence. We discuss a set of
five core interrelated issues about evidence, examining
(1) how the evidence base is determined, (2) context,
(3) health equity, (4) policy implementation, and (5)
audience/stakeholder perspectives. All areas concern
some form of research or knowledge gaps in D&I science. The evidence base discussion presents a broader
perspective on what is considered evidence; the context, equity, and stakeholder sections cover neglected
aspects of implementation science in need of more and
higher quality research; and the policy implementation
section points to the need for the most pressing gaps
in policy-relevant research for D&I. Across these areas,
we provide a series of recommendations along with
tools and resources for speeding translation of research
to practice and policy.

Selected debates about evidence
Here, we describe ongoing discussions and debates about
the uses, usefulness, and gaps in evidence for implementation science, which give way to our recommendations
(Table 4). While this is not an exhaustive list, it illustrates the
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need for more reflection and clarity across five core areas
where there are major unresolved issues about evidence.
Reconsider how the evidence base is determined

The evidence base for implementation science needs
to be broadened to encompass a wider range of study
designs, methods, stakeholders, and outcomes. For example, the decontextualized randomized controlled efficacy
trial (RCT) that attempts to control for many potential
confounding factors is generally considered the gold
standard for obtaining evidence on internal validity and
contributing to the determination of causality of a given
intervention, practice, or treatment [45]. A property of an
RCT is that, with large sample sizes, it allows researchers
to potentially balance known and unknown confounders. Despite the value and conceptual simplicity of the
traditional efficacy RCT, its limitations have been noted
[46–48]. For example, randomization may be impractical,
costly, or unethical for some interventions (e.g., community-based interventions where partners have concerns
about withholding a program from the community) and
for many policy interventions, where the independent
variable (the “exposure”) cannot be randomized. Tools
such as PRECIS-2 and the newer PRECIS-2 PS help
enhance the real-world utility of RCTs (pragmatic trials)
[49, 50]. For some settings and interventions, alternative
and more rapid-cycle and adaptive designs are needed
to elucidate effects including quasi-experiments, observational trials, iterative assessments and actions, natural experiments, and mixed-methods studies [51–55].
Often in implementation science what we want to know
is how one strategy adds to a range of strategies already
being delivered within an existing environment a concept
called “mosaic effectiveness” [56].
For clinical and public health practice, the generalizability of an EBI’s effectiveness from one population and setting
to another (and ideally across a diverse range of populations
and settings)—the core concept of external validity—is an
essential ingredient. Systematic review and practice guidelines, which are often the basis for an implementation study,
are mainly focused on whether an intervention is effective
on average (internal validity) and have commonly given
limited attention to specifying conditions (settings, populations, circumstances) under which a program is and is not
effective [57–59]. For implementation science, there are
many considerations and layers to the notion of whether
an evidence-based practice applies in a particular setting or
population [59]. Tools such as ADAPT [60] or process models like ADAPT-ITT [61] can be useful in transferring EBIs
from one setting to another while taking contextual variables into account. Models such as FRAME and FRAMEIS are helpful for tracking and building the evidence base
around what types of adaptations are associated with
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Table 2 Contextual variables for implementation across ecological levels
Ecological level

Examples

Individual

Education level
Race/ethnicity/age/gender
Geography/rurality
Basic human n
 eedsa
Personal health history
Readiness/motivation to undergo testing or therapy
Literacy and numeracy
Trust, mistrust, distrust
Stigma
Stress and distress
Resilience
Genotype and phenotype
Motivation
Values

Interpersonal

Family health history
Support from peers
Social capital
Social networks
Social support from family, friends, coworkers, healthcare providers

Organizational

Staff composition
Staff expertise, experience, and skills
Physical infrastructure
Organizational and financial resources
Organizational climate and culture
Leadership
Degree of participatory decision-making
Density of organizational ties
Centrality of agencies in a community
Institutional racism
Psychological safety
Mission and priorities
Guidelines and incentives
Processes and procedures
Training and retraining
Norms
Stability

Socio-cultural and community

Social norms and values
Cultural norms, values, traditions
Health equity
History
Societal stigma
Community capacity, priorities, assets
Local resources and investments
Structural racism
Shared mental models
Neighborhood characteristics
Access to healthcare and health promoting resources

Political and economic structures and systems

Societal values
Political will
Political ideology
Lobbying and special interests
Costs and benefits
Professional guidelines
Policies and regulations (both Big P and small p)

It is not anticipated that any single study would address this full list of variables; rather, this is a set of examples that can be described and narrowed via review of the
literature, formative research, and stakeholder engagement
a

Basic human needs include food, shelter, warmth, safety

improved or decreased effectiveness or implementation
outcomes (and for which settings and populations?) [62, 63].
The question of whether an EBI applies involves a set
of scientific considerations that may differ from simply

knowing average treatment effects. These include balancing of fidelity to the original EBI functions with
adaptations needed for replication and scale-up [64], as
well as considerations as to when there may be a need
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Table 3 Determining when evidence is sufficient for dissemination and implementation
° How pressing is the health issue?
° Is there an EBI? If so, what is the quality and quantity of evidence on the EBI?
° How long will it take to develop the evidence base?
° Are there emerging or established health equity issues?
° If the study addresses social or structural determinants, might multiple health conditions benefit?
° Is the issue a priority among stakeholders? How many? Which ones?
° Are you equipped to measure a range of contextual variables?
° Are there resources to implement a study?
° Might a hybrid trial that addresses both effectiveness and implementation, be appropriate?
° Is there implementation already happening that you might evaluate?
° Is action going to be taken regardless of whether the program or policy is evidence-based or not?
° What are the consequences of not implementing?
° What are the consequences of getting it wrong?

to “start from scratch” in developing a new intervention
as opposed to refining or adapting an existing one (e.g.,
when the nature of the evidence for an EBI does not fit
the sociocultural or community context). There is a pressing need for research on the strengths and limitations of
practitioner-driven and community-centered adaptation
of EBIs, which is likely to enhance relevance, feasibility,
and sociocultural appropriateness and acceptability, as
well as fit with implementation context [65–67]. There
are also potential considerations when adapting EBIs or
implementation strategies (e.g., costs, resources needed,
potential reduction in effectiveness) [63, 68, 69]. It has
also been suggested that a greater emphasis is needed on
both the functions of an intervention (its basic purposes,
underlying theoretical premise) and forms (the strategies
and approaches used to meet each intervention function) [64], opening the door to inquiry about how fidelity to function may demand adaptations (or in some cases
transformation or evolution) in form.
Additional evidence is needed on the inter-related
concepts of null (ineffective) interventions, de-implementation, and mis-implementation [70–72]. From null
intervention results, we can learn which parts of an EBI
or implementation strategy need to be refined, adapted,
or re-invented. Data on null interventions also informs
for whom and under what conditions an EBI or implementation strategy is “evidence-based.” De-implementation is the process of stopping or abandoning practices
that are not proved to be effective or are possibly harmful [73], whereas mis-implementation involves one or
both of two processes: the discontinuation of effective
programs and the continuation of ineffective practices in
public health settings [70]. Many of the contextual variables in Table 2 strongly affect de-implementation and
mis-implementation.
Emerging perspectives in data science and causal inference may help advance type 3 evidence. If contextual
heterogeneity is the norm, then the scientific task in any
one study population is to produce data that address

relevance across diverse external settings. Useful methods to do so are becoming available and suggest that the
more we know about mediators/mechanisms and modifiers of effects in implementation, the more interpretable
findings could be in different settings and populations
[74–76]. For example, consider the question of whether
evidence for audit and feedback on the use of EBIs in
HIV clinics from randomized trials in Boston could apply
to HIV clinics in Nairobi, Kenya. Let us assume that in
Boston, researchers learn that the credibility of the data
is a key driver of successful implementation (e.g., clinicians who doubt the veracity of metrics from the electronic health record are less likely to respond). Given the
widespread challenges of data accuracy in the nascent
electronic health records in this specific setting in Africa
(and extensive literature documenting this challenge),
audit and feedback as an implementation strategy can be
anticipated to have limited implementation relevance as
well as effectiveness. Using data from Boston to infer (in
this case that it might not work) in Nairobi depends on
knowing critical mediators of audit and feedback in Boston (i.e., the credibility of data on provider performance).
In some situations, a completely different implementation strategy may be needed that is better suited to local
conditions. One further implication is that this directs
research efforts to not only find effects in Boston, but
how they came about (type 3 evidence).
Improve understanding of contextual effects
on implementation

The complexity and dynamic nature of implementation
necessitate continual attention to context (i.e., active and
unique factors that surround implementation and sustainability [77, 78]) [22, 79, 80]. When context is taken
into account in research, the study findings are more
likely to indicate the conditions under which evidence
does or does not generalize to different populations,
settings, and time periods [23]—yet too often context
is inadequately described or not fully elucidated [81].

Rationale
The choice and strength of study design is dependent
on the research questions and setting, particularly the
context for the study

Much of the existing evidence base is developed by
university researchers in high-resource settings

The research enterprise (review processes, conducting research, publishing and disseminating research)
moves slowly, often much more slowly than practice
and policy

Biases are often present in small scale studies that are
not taken into account in larger studies or studies do
not account for context

Recommendation

1. Use an evidence typology rather than an evidence
hierarchy

2. Increase focus on practice-based and communitydefined evidence

3. Speed the pace of evidence development

4. Address potential biases in implementation

Domain

Evidence base

Table 4 Recommendations to advance evidence and implementation science
Actorsa

• Reconfigure small scale studies to account for generalizability biases (bias in intervention intensity, implementation support, delivery agent, target audience,
duration, setting, measurement, resources required,
directional conclusion, outcome)
• Specify which communities, organizations, staff, and
individuals are included and which are excluded and
why at multiple levels and stages of a study, and their
characteristics

• Conduct rapid reviews/living syntheses (so-called
living meta-analyses)
• Use rapid methods, designs, analyses
• Bring together practitioners, researchers, community
members, and policy makers to identify promising
innovations in need of evaluation (including realist
evaluation)
• Reorient funding mechanisms to be more adaptive
and flexible, and to support rapid-cycle evaluation
(e.g., quick addition of measures to existing studies)

• Researchers
• Practitioners

• Funders
• Researchers
• Practitioners
• Policy makers

• Strike a better balance between explicit (research)
• Funders
• Researchers
knowledge and tacit (lived experience) knowledge
• Practitioners
• Conduct practice-based research, particularly for
low-resource settings and settings that face numerous structural and social impediments to health and
well-being
• Engage multi-level stakeholders and practice-based
partners in substantive and meaningful ways in the
context of and beyond research and research grants,
including identifying stakeholder prioritized issues and
outcomes

• Identify and implement alternatives and modifica• Funders
tions (e.g., natural experiments; interrupted time series, • Researchers
adaptive designs, systems modeling, mixed methods, • Policy makersb
participatory modeling, multi-level pragmatic trials,
policy implementation) to the efficacy RCT
• Match the research question with the study design,
balanced with considerations of rigor and pragmatism

Potential solutions
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Rationale
When context is taken into account in research, study
findings are more applicable to different populations,
settings, and time periods

Pragmatic methods show promise by engaging
multiple stakeholders, heterogeneous settings, and
real-world conditions

There are particular challenges and opportunities for
development of new evidence in LMICs

The process of modifying and refining EBIs and implementation strategies has not been well documented
and understood

Recommendation

5. Document ways in which context drives implementation

6. Further develop pragmatic methods and measures
to assess and address context

7. Apply lessons from LMICs and other low-resource
settings

8. Further develop the science of adaptation

Domain

Context

Table 4 (continued)
Actorsa

• Apply tools such as FRAME, FRAME IS, and other
emerging coding systems to address and study key
considerations in adaptation (e.g., when and how
adaptations occur, whether planned or unplanned,
their impact)
• Use adaptation process models to guide cultural and
contextual adaptations to address fit and dynamic
context, while also remaining true to the original
function
• Better link implementation with the field of cultural
adaptation to enhance the reach and equity of EBIs
• Investigate ways of guiding adaptations that center
on equity and investigate contexts in which EBIs
may be adapted successfully versus when new EBIs
may need to be developed to address specific health
issues, historical experiences of populations, or sociocultural contexts

• Document and seek to replicate conditions under
which innovations emerge and thrive
• Apply principles of transportability research across
different countries and diverse settings that have a
range of capacity, resources, and infrastructure
• Apply findings from task shifting research

• Make use of pragmatic measures (e.g., those that are
user-friendly, sensitive to change, low cost, important
to practitioners)
• Apply pragmatic tools such as PRECIS-2 PS
• Make use of guidelines to develop and evaluate
complex interventions (e.g., the MRC guidance)

• Funders
• Researchers
• Practitioners

• Funders
• Researchers
• Practitioners

• Researchers
• Practitioners

• Employ new theories, models, and frameworks (e.g.,
• Researchers
Normalization Process Theory) to understand context, • Practitioners
including ones outside the field of implementation
science that address social and community context
in depth
• Use mixed-methods and user-centered design
approaches to study context, particularly at organizational, community, policy, and society levels
• Define and apply contextual variables that lead to
effective replication and may facilitate sustainability
and scale-up
• Investigate mechanisms of implementation strategies
to enable greater generalization into different contexts

Potential solutions
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Rationale
Much of the evidence base is narrowly developed
on diseases and risk behaviors, neglecting root and
structural causes; many EBIs have not been evaluated
among populations and settings experiencing inequities

Equity has been under-addressed in implementation
science and should be a feature of all studies

Recommendation

9. Place greater emphasis on social determinants and
structural factors that shape health inequities and
inequitable implementation

10. Integrate equity-relevant methods and measures

Domain

Health equity

Table 4 (continued)

• Funders
• Researchers
• Practitioners

Actorsa

• Develop and apply models and frameworks that
• Funders
place a central focus on equity in both determinants
• Researchers
and outcomes
• Practitioners
• Determine how well existing implementation
strategies apply to a range of diverse populations and
settings facing social and health inequities
• Explicitly measure and track health equity, health
inequities, and their determinants (structural racism)
and how they are reduced or exacerbated by EBIs/
strategies
• Consider and track differential indicators of implementation (e.g., reach, feasibility, acceptability, appropriateness, adoption, implementation, sustainability)
across different social groups (e.g., by race, ethnicity,
age, gender, sexual orientation) or settings (e.g., urban,
rural)
• Prioritize equity indicators and determinants based
on community and stakeholder input.

• Show the value and impact of interventions that
address health equity, root causes, and social determinants
• Include structural racism and other equity relevant
structural factors (economic inequality, stigma) in
measures, frameworks, and models in assessing
context and barriers/facilitators to implementation, or
in planning for implementation
• Map the pathways and mechanism through which
upstream interventions operate to impact more
proximal downstream factors and ultimately health
inequities
• Identify interventions that consider social context,
prioritize community priorities, and build off existing
community strengths/assets

Potential solutions
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Despite its potential impact, there are many gaps in
policy implementation research

Other disciplines (e.g., political science, law, sociology)
have a long history of policy research that is relevant
to implementation scientists

For effective dissemination of policy information,
tailoring of messages and channels is needed

Implementation research can be informed by audience segmentation principles, which were developed
outside the health sector

Individuals interpret the same data in different ways
depending on the mental model through which they
perceive information

11. Expand the scope of policy implementation
research

12. Apply concepts from other fields to policy implementation research

13. Expand knowledge of the spread of policy-relevant
information

14. Apply principles of audience segmentation and
human-centered or user-centered design

15. Apply principles of framing and other communication strategies

Policy implementation

Individuals, groups, and community partners most likely to take action to address the recommendation

Policy makers include those addressing both Big P and small p policies

b

• Researchers
• Policy makers

• Apply theories from other fields to policy implementation in health
• Use principles of team science to build new and
vibrant transdisciplinary teams
• Seek to understand the culture, norms, processes,
and context of policy makers

• Researchers
• Practitioners

• Compare the effectiveness of gain versus loss framing • Funders
to various audiences
• Researchers
• Identify ways in which framing in policy advocacy
• Policy makers
can be applied to implementation science
• Apply principles of narrative communication to
framing to turn scientific evidence into meaningful
narratives for specific audiences

• Select and describe characteristics of discrete audiences for dissemination and implementation
• Engage community members/patients as a core
audience with a commitment to return research
evidence to those affected
• Develop messages and channels of high salience
to various stakeholders (e.g., visually appealing, brief
summaries for policy makers)
• Apply audience segmentation approaches from the
marketing world

• Researchers
• Compare different messaging strategies for policy
makers (e.g., social good versus cost-savings, return on • Policy makers
investments)
• Expand knowledge of the role of social media in
policy implementation research (e.g., disseminating
research, understanding the socio-political environment)
• Expand knowledge on how to combat mis- and disinformation in policy implementation

• Funders
• Researchers
• Policy makers

Actorsa

• Focus on structural interventions and communitydefined interventions and policies and consider both
health and social policies (that have health impacts)
• Determine ways in which to build equity in all policies
• Study how the meaning of evidence and processes
are shaped via the interactions between policy implementation and practice change
• Develop reliable and valid measures for policy
implementation

Potential solutions

(2022) 17:26

a

Audience differences

Rationale

Recommendation

Domain

Table 4 (continued)
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Contextual conditions also drive and inform the adaptation of EBIs to populations and settings that differ from
those in which it originally developed [82]. It is useful to
consider contextual issues of relevance for implementation across levels of a socio-ecological framework (individual, interpersonal, organizational, community, policy)
(Table 2) [79].
The challenging scientific task of “unpacking” context
requires three activities. First, contextual effects in any
study setting or across settings and/or systems should be
enumerated (e.g., a set of variables in Table 2). Second,
since one cannot measure everything, part of building
the evidence base involves determining which aspects of
context are most salient for implementation within and
across settings. Third, implementation research should
also seek to measure the presence, distribution, and
intensity of those contextual factors in target settings
in which a research study is not being undertaken, but
where one might want to apply evidence.
Within an implementation research project, context
is dynamic and should be assessed across all stages of
a study [83]. Too often, dynamic contexts are not fully
understood or assessed [30]. In some cases, the context for delivery (e.g., a particular clinical setting) is
relatively stable, but the target of the intervention (e.g.,
a particular pathophysiology; guidelines for cancer
screening) is dynamic and emergent. In a more complex intervention trial, both context and targets are
dynamic and emergent [22, 84].
During implementation planning, a needs and assets
assessment (formative research) should account for historical, cultural, social, and system factors that may
shape implementation and the implementation climate,
including forms of structural or institutional racism (e.g.,
inequitable practices and policies), medical mistrust,
institutional and providers’ biases and norms that may
create or reinforce biases or inequities, as well as community strengths and assets that may inform implementation efforts. Tools such as critical ethnography can be
useful during needs assessment to understand interactions between the ensembles of actors, agencies, interventions, and other contextual variables [85]. When
selecting EBIs to be tested in an implementation study,
context may affect both internal validity and external
validity. Systematic reviews, which are often the source of
EBIs, use a relatively narrow hierarchy of evidence [86]
and tend to strip out implementation context when trying to make a summary (often quantitative) judgement
about the average effectiveness of an EBI (e.g. for most
populations and settings). For many settings in which we
are conducting implementation studies (e.g., lower- and
middle-income countries [87]), we may not have a strong
evidence base, guidelines, or interventions that have been
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tested through “gold-standard” RCTs and if they have,
they are often not under conditions similar to those in
which the EBI will now be applied.
Context in global settings presents unique considerations, particularly in lower- and middle-income countries
(LMICs) and other settings that have limited resources
and face numerous structural barriers to health (e.g., in
the USA, federally qualified health centers, donor-funded
vertical health programs in lower- and middle-income
countries). Among the considerations is the relevant evidence base for implementation—when settings vary tremendously, particularly the social and political context
and systems/organizational infrastructure: Do researchers and implementers need to start anew in building the
evidence base for implementation, answering many of
the questions in Table 3? There is some evidence that in
settings with constrained resources, intervention and
methods innovations may be fostered due to the need for
creativity and adaptations (e.g., task shifting [88]) when
choices are restricted [89]). Adaptive designs (where
interventions and strategies are modified in response to
emerging data) may be particularly useful in LMICs since
they may allow a team to begin with low-intensity/lowresource approaches, and refine or intensify as needed
[90–92].
Transportability theory has been applied to assess
whether findings about the effects of an implementation
strategy in one setting can be used to infer in another,
and if so, whether it is likely to work [93]. Context, when
defined narrowly as the causes of an outcome that differ
from one setting to another, asks science to focus on two
measurement tasks. In the initial context where a strategy
is being tested, it will be important to measure the steps
that mediate or moderate the effects of the strategy on
the outcome as well as factors that influence those steps.
Hypotheses not only about effects but also about how
and why they occur across diverse settings are important
to inform the measurement architecture.
Context is also important during the process of broader
dissemination of evidence-based approaches. There is
a well-documented disconnect between how researchers disseminate their findings (including EBIs) and how
practitioners and policy makers learn about the latest
evidence [14]. Applying principles of designing for dissemination (D4D) allows researchers to better account
for the needs, assets, priorities, and time frames of
potential adopters and stakeholders [94, 95]. An active
D4D process emphasizes the design phase of an implementation research project. A D4D process anticipates
dissemination of products (e.g., an evidence-based implementation strategy) by developing a dissemination plan
that takes into account audience differences, product
messaging, channels, and packaging [96]. In the future,
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this proactive D4D process could usefully more fully
address designing for equity and sustainment, as well as
dissemination.
Sharpen the focus on health equity

Addressing heath disparities and promoting health
equity is becoming a more central and explicit focus of
implementation science [92, 97–102]. Health equity is
a framing that shifts from a deficits approach (disparities) to one focused on what society can achieve (equity)
[103]. An equity focus also recognizes the unjust nature
of inequities, naming root/structural causes [104]. This
emphasis is documented in publication trends over
the past two decades. Figure 1 shows trends of publications from January 1, 2000, to December 31, 2021,
using two search strings in PubMed: 1) “health disparities” AND [“implementation science” OR “implementation research” or “knowledge translation”] and 2) “health
equity” AND [“implementation science” OR “implementation research” or “knowledge translation”]. For most
of the past two decades, research has been framed more
often with a disparities focus than with an equity focus—
disparity publications were two- to three-fold more common than equity articles from 2006 to 2014. However, in
2021, the number of equity-framed publications greatly
exceeded the number of disparities-framed publications.
To move towards the goal of achieving health equity,
it is critical that implementation science expands the
quantity, quality, and types of evidence produced and
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prioritized, as well as who and what settings are (1)
reflected in that evidence (representativeness) and (2)
involved in its generation and interpretation (representation). For many health conditions and populations, we
have adequate descriptive (type 1) data that can guide
what to address (e.g., the size and nature of disparities).
However, we often lack sufficient data on EBIs and strategies that are effective in reducing inequities and/or promoting equity [92]. Often, available EBIs inadequately
address or account for many relevant social, cultural,
structural, and contextual conditions that shape both
health inequities and have implications for EBI implementation [92, 105, 106]. There are challenges in generating evidence on inequities, including potentially smaller
sample sizes across various social dimensions through
which inequities exist, which may limit subgroup heterogeneity analyses (e.g., by race or ethnicity) [107, 108] (see
Table 2). As we build the evidence base of EBIs to actively
promote equity, there is a need to understand the core
elements of equity-focused interventions and strategies,
and to do so for the range of social dimensions through
which health inequities may exist (e.g., race, immigration status, gender, sexual orientation, location) and their
intersection [109].
A foundational challenge here is that many EBIs were
not developed with or tested among settings or populations that experience inequities or with the goal of promoting health equity and may unintentionally contribute
to or exacerbate inequities [110–112]. This results in part

Fig. 1 Number of annual publications on health disparities and health equity
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from the reductionist way in which EBIs are often developed, deployed (a linear, “cause and effect” approach),
and tested [113], paying inadequate attention to the complex and interrelated social determinants of health and
root causes of health inequities (e.g., structural racism,
inequitable allocation of resources and opportunities)
[114–118].
We need to engage a wider range of partners from lower
resource settings earlier and throughout the research
process and in meaningful ways to build a broader and
more relevant array of equity-focused EBIs that are feasible, acceptable, culturally appropriate, and address root
causes. We also need to expand what we “count” as EBIs
in public health and clinical research, broadening the
focus from a narrower view of individual, interpersonal,
and organizational interventions, to also include community, policy, and multi-sector interventions that have
the potential to make larger shifts in health inequities.
Such broadening of evidence with an eye towards health
equity will consider moving beyond a more singular
focus on our EBI repositories and including and evaluating existing promising community-defined evidence and
interventions [92, 119, 120]. In expanding the evidencebase with the goal of promoting health equity, there are
significant opportunities to develop and deploy EBIs in
sectors outside of health (e.g., schools, workplaces, social
services agencies, juvenile justice settings) where in many
cases, the reach and impact can be greater than in the
health sector [121]. Additionally, as we expand this evidence base, it may be beneficial to prioritize development
and evaluation of interventions, practices, and policies
that can reduce underlying structural and social factors
(e.g., structural racism) and their downstream effects on
health inequities [120].
Equity should be a core criterion for valuing evidence.
This value statement should be reflected in priorities
of funders, how research questions are framed, how
research resources and decision-making are distributed,
and how studies are conducted, evaluated, and reviewed.
Implementation science has a role in recognizing that a
negative consequence of our social and economic systems is the concentration of resources and health. These
systems create inequities, so when thinking about closing an implementation gap, we should recognize the
context—that such a gap is often an outgrowth of these
systems and must be addressed and transformed. Equity
needs to be prioritized and made more explicit as part
of engagement efforts, which includes consideration of
power imbalances (who is and is not involved in making key decisions) and timing of when and how partners
are engaged (e.g., who is involved in EBI development
and deployment, how communities are reflected in cocreating the evidence) [95, 120]. Reflection questions and
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step-by-step guidance can help guide study planning with
an equity focus [102, 120].
Conduct more policy implementation research
and evaluation

Health and social policies, in the form of laws, regulations, organizational practices, and funding priorities,
have a substantial impact on the health and well-being of
populations and create the conditions under which people can be healthy and thrive- or not [122, 123]. Clinical
and public health guidelines inform policy implementation by providing the basis for legislation, informing covered services in health plans, and advancing policies that
support health equity [124–128]. Policies often address
the underlying social and structural conditions that shape
health and inequities—this in turn provides opportunities for policy implementation to frame accountability for
organizations and systems.
Policy implementation research, which has been conducted since the 1970s across multiple disciplines [129,
130], seeks to understand the complexities of the policy
process and increase the likelihood that evidence reaches
policymakers and influences their decisions so that the
population health benefits of scientific progress are maximized [131]. A key objective of policy implementation
research is the enactment, enforcement, and evaluation
of evidence-based policies to (1) understand approaches
to enhance the likelihood of policy adoption (process);
(2) identify specific policy elements likely to be effective (content); and (3) document the potential impact of
policy (outcomes) [132]. Especially in the USA, policy
implementation research is underdeveloped compared
to other areas in implementation science. For example, a
content analysis of all projects funded by the US National
Institutes of Health through implementation research
program announcements found that only 8% of funded
grants were on policy implementation researc h[133].
Few of these studies had an explicit focus on equity or
social determinants of health.
Policy researchers have utilized a variety of designs,
methods, and data sources to investigate the development processes, content, and outcomes of policies. Much
more evidence is needed, including which policies work
and which do not (for what outcomes, settings, and populations), how policies should be developed and implemented, unintended consequences of policies, and the
best ways to combine quantitative and qualitative methods for evaluation of “upstream” factors that have important implications for health equity [134]. There is also a
pressing need for reliable and valid measures of policy
implementation processes [135]. These knowledge gaps
are unlikely to be addressed by randomized designs and
are more likely to be addressed using quasi-experimental
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designs, natural experiments, stakeholder-driven adaptations, systems science methods, citizen science, and participatory approaches [51, 66, 136–139].
Several other areas in policy implementation research
need attention. First, policy makers often need information on a much shorter time frame than researchers can
deliver—this calls for the use of tools such as rapid-cycle
research [140] and rapid realist reviews [141]. Second, we
need to better understand the spread of policies, including the reasons that ineffective policies spread [142], the
role of social media [131], and ways to address mis- and
dis-information in the policy process [143]. Finally, more
emphasis is needed on the reciprocal, often horizontal,
interactions between organizations and the development
of policy-relevant evidence [144]. For this inter-organizational research, the role of policy intermediaries (those
who work in between existing systems to achieve a policy goal) has gained attention due to their critical roles
in policy implementation research [145]. Strategies and
tools to address several of these issues are provided in
recent reviews [146, 147] and in Table 4.
Pay greater attention to audience and stakeholder
differences

There are multiple audiences of relevance for developing,
applying, disseminating, and sustaining the evidence for
implementation science [148]. When seeking effective
methods to generate, implement, and sustain EBIs, it is
important to take into account the characteristics of each
audience and stakeholder group, what they value, how to
balance different viewpoints, and how to combine stakeholders’ experience and research evidence. Across these
stakeholder groups, research evidence is only one of
many influential factors influencing adoption, implementation, and sustainment of EBI [6, 15, 40].
Key audience categories include researchers, practitioners, and policy makers (Table 5). Researchers are
one core audience. These individuals typically have specialized training and may devote an entire career studying a particular health issue. Another audience includes
clinical and public health practitioners who seek practical information on the scope and quality of evidence for a
range of EBIs and implementation strategies that are relevant in their setting. Practitioners in clinical settings (e.g.,
nurses, physicians) have specialized and standardized
training whereas the training for public health practitioners is highly variable (most public health practitioners
lack a public health degree [149]). A third group is policy
makers at local, regional, state, national, and international
levels. These individuals are faced with macro-level decisions on how to allocate public resources. Policy makers
seek out distributional consequences (i.e., who has to pay,
how much, and who benefits) [150] and in many policy
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settings, anecdotes are prioritized over empirical data [9].
The category of policy makers also includes funders—
these funders may be elected officials and “small p” policy
makers (organizational leaders) who make funding decisions within their settings.
The relevance and usefulness of evidence vary by stakeholder type (Table 5) [151]. Research usefulness can be
informed by audience segmentation, where a product
promotion strategy is targeted to the characteristics of a
desired segment—a widely accepted principle in marketing [152]. Audience segmentation can be informed by the
process of user-centered design and decision-centered
processes, in which the product (e.g., an implementation
strategy) is guided in a systematic way by the end-users
of the product [153–155].
Framing is another important factor in considering audiences for D&I. Individuals interpret the same
data in different ways depending on the mental model
through which they perceive information [156]. For
example, policy makers often perceive risks and benefits
not in scientific terms but in relation to (usually short
term) emotional, moral, financial, or political frameworks [157, 158]. In practical terms for implementation
science, framing for a particular health issue for a community member or patient might relate to the ability to
raise healthy children whereas framing for a policy maker
might relate to cost savings from action or inaction. Cost
and economic evaluation are key considerations for a
range of stakeholders involved in implementation, yet too
often the perspectives of diverse stakeholders are not well
considered, acted upon, or reported [159].

Next steps for addressing gaps
The “how-to” for broadening the evidence base for implementation science will require several actions. First, we
need to prioritize the evidence gaps and possible ways of
filling these gaps—many ideas are shown in Table 4. Next,
resources and tools are needed to address evidence deficits (Table 6). All tools listed are available free of charge
and provide enough background and instructions to
make them useful for a wide range of users—from beginners to experts. The tools listed cover multiple, overlapping domains: (1) engagement and partnerships; (2) study
planning; (3) research proposals, articles, reporting, and
guidelines; (4) and dissemination, scale-up, and sustainability. In addition to the resources in Table 6, there are
many other portals that provide valuable information and
resources for implementation research across multiple
domains (e.g., technical assistance, mentorship, conferences, archived slides, webinars) [160–168].
Capacity is a core element for building a stronger, more
comprehensive, and equitable evidence base. Capacity
can be developed in multiple ways, including supporting

Policy makers include funders of research

External factors commonly include habit, stereotypes, and cultural norms

b

Time, lack of access to peer-reviewed evidence,
lack of incentives, low priority of leadership, perceived lack of relevance, competing demands

Time, predominant focus on RCTs, lack of attention to context, slow speed of research

Barriers to the use of evidence

a

Science, evidence reviews, real-world experience
Real-world stories, constituents, gatekeepers, party
from the field, personal experience, local evidence priorities, media, science, policy briefs

Science, evidence reviews, experimental
experience from the field, general evidence

Primary types of evidence relied upon

Time, lack of interest, complexity of evidence, new
demands, rapidly changing context

Adoption, implementation, dissemination, sustainment, funding

Planning, evaluation, implementation, dissemination, sustainment

Generation, synthesis, publication, implementation, dissemination

Role in the evidence development process

Shorter

Moderate

Longer

High

Less depth, wider breadth

Moderate to high

Generalized

Shorter

Policy makera

Time spent on a particular issue

Moderate

Moderate to high
Moderate knowledge on wide set of issues (often
more specialized in larger agencies)

Low
Deeper knowledge on a small number of issues

Personal connection to constituents

Knowledge span

Decisio-making based on external factorsb Low

Middle to longer
Specialized for some, but generalized for others

Longer
Specialized

Time in position

Training

Practitioner (clinical, public health)

Researcher

Characteristic

Table 5 Differences in evidence-related characteristics and needs among audiences
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This practice-oriented toolkit leads agencies,
teams, community-based organizations, and
community partnerships through different public
health processes using a health equity lens. The
modules include interactive reflection questions
across a framework for evidence-based decisionmaking.
The Navigator is designed to help teams select
the most appropriate engagement method or
tool for a particular project. It is an interactive tool
that takes into account the purpose, resources,
frequency of engagement, and expertise.
An interactive, online resource designed to help
researchers and practitioners navigate dissemination and implementation theories, models, and
frameworks through planning, selecting, combining, adapting, using, and linking to measures.
Newly added frameworks address the interface
between health equity and implementation science.
T-CaST offers explicit criteria to facilitate theory
comparison during the selection process. The
tool is also potentially useful in selecting theories,
models, and framework beyond the field of implementation science.

PRECIS-2 is a tool to help in designing health
https://www.precis-2.org/
services research and to consider where a trial lies https://implementationscience.biomedcentral.com/
across 9 dimensions across the pragmatic/explana- articles/10.1186/s13012-020-01075-y
tory (efficacy) continuum; the newer PRECIS-2 PS
is focused on designs related to provider strategies
for implementation studies.
The APEASE criteria provide a framework for assessing interventions, intervention components, and
ideas. APEASE can be applied to anything from a
general concept to a detailed plan for a proposed
intervention, or a formal evaluation of an intervention that has already been implemented.

Advancing Health Equity Toolkit

Stakeholder Engagement Navigator

Dissemination and Implementation Models in
Health Research and Practice

T-CaST (Theory, Model, and Framework Comparison and Selection Tool)

PRECIS-2 (PRagmatic Explanatory Continuum
Indicator Summary) and PRECIS-2 PS

APEASE (Acceptability, Practicability, Effectiveness,
Affordability, Side-effects, and Equity)

Study planning

https://engageforequity.org/tool_kit/
The tools provide a step-by-step approach for
research partnerships to examine where they are
now and where they want to be in the future. Each
step includes a short description and an interactive
exercise or tool.

Engage for Equity

(2022) 17:26

https://assets.publishing.service.gov.uk/gover
nment/uploads/system/uploads/attachment_data/
file/875385/PHEBI_Achieving_Behaviour_Change_
Local_Government.pdf

https://impsci.tracs.unc.edu/tcast/

https://dissemination-implementation.org/

https://dicemethods.org/Tool

Home | Evidence-Based Decision Making & Health
Equity (wixsite.com)

https://ctb.ku.edu/en

The Community Tool Box is a free, online resource
for those working to build healthier communities
and bring about social change. The Tool Box seeks
to promote community health and development
by connecting people, ideas, and resources.

Community Tool Box

Engagement and partnerships

Weblink

Description

Name

Category

Table 6 Selected resources and tools to support practice and research on evidence-based dissemination and implementation
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Category

Table 6 (continued)

This website is designed to help policy researchers, evaluators, and implementation science
researchers identify and select measures to assess
the implementation of health policies in a variety
of settings (e.g., hospitals, outpatient clinics, neighborhoods, schools).

https://www.health-policy-measures.org/

This tool is a compilation of resources, tools, and
cost-annoat-biblio-disc-one-pager-3122119e99
fe6302864d9a5bff f0a001ce385.pdf (cuanschutz.edu)
studies about cost/cost-effectiveness research in
implementation science. It covers costing methods
and cost-effectiveness analyses that are important
for measuring and improving the value of healthcare and public health practices.

Annotated Bibliography of Economic Analysis
Resources for Implementation Science

Measuring Health Policy Implementation

At any stage of implementation, the Hexagon Tool
can be used by communities and organizations to
better understand how a new or existing program
or practice fits into an implementing site’s existing
work and context.

The Hexagon Tool

https://nirn.fpg.unc.edu/resources/hexagon-explo
ration-tool

MOST is a research framework, based on engineer- https://www.hvresearch.org/precision-home-visit
ing principles, for determining the most efficient
ing/innovative-methods/multiphase-optimization-
and effective version of an intervention. It uses a
strategy-most/
3-phase approach to assess the effectiveness of
individual program elements and consider whether
effectiveness varies depending on context.

MOST (Multiphase Optimization Strategy)

Weblink

Description

Name
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The expanded CONSORT includes data about par- https://www.re-aim.org/expanded-consort-figure-
ticipation and representativeness at multiple levels for-planning-and-reporting-d-i-research/
of settings, as well as staff and individual recipients,
and about intervention sustainability after project
support ends. It adds a focus on transparent
reporting of inclusions, exclusions, and participation at multiple levels and includes a fillable PDF
for manuscript submissions.
StaRI is used for reporting of implementation
studies, which employ a range of study designs to
develop and evaluate implementation strategies
with the aim of enhancing adoption and sustainability of effective interventions

Expanded CONSORT (Consolidated Standards of
Reporting Trials)

Standards for Reporting Implementation Studies
(StaRI) Statement

https://www.equator-network.org/reporting-guide
lines/stari-statement/

GRADE is a transparent framework for developing and presenting summaries of evidence and
provides a systematic approach for making clinical
practice recommendations.

GRADE (Grading of Recommendations, Assessment, Development and Evaluations)

https://bestpractice.bmj.com/info/us/toolkit/learn-
ebm/what-is-grade/

This tool assesses research proposals for their
https://ajph.aphapublications.org/doi/suppl/10.
sensitivity to health equity issues. The tool consists 2105/AJPH.2019.305221
of a series of questions that prompt for evaluation
of how well equity issues have been considered in
terms of the population context, study rationale,
intervention design, sample design, data collection
and analysis plan, evidence of community engagement, and team composition.

Tool for Rating Research Proposals for Sensitivity to
Health Equity Issues

Research proposals, articles, reporting, and guidelines

Weblink

Description

Name

Category
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Brownson et al. Implementation Science
(2022) 17:26
Page 19 of 25

https://www.sustaintool.org/csat/

The CSAT measures the sustainability of evidencebased practices in clinical settings. Users receive
a tailored report that can be used by clinical and
healthcare settings to plan for and implement
changes within their organization.

The PSAT measures the sustainability of evidence- https://www.sustaintool.org/psat/
based practices in community settings. Users
receive a tailored report that can be used by public
health and community organizations to plan for
and implement changes within their organization.

Clinical Assessment Sustainability Tool (CSAT)

Program Assessment Sustainability Tool (PSAT)

This table is illustrative and is not meant to be comprehensive. We have focused on sources that are more regularly updated

https://expandnet.net/

A global network of representatives from
international organizations, non-governmental
organizations, academic and research institutions,
ministries of health, and specific projects who seek
to advance the science and practice of scaling up

ExpandNet

A tool to help researchers evaluate their research
https://www.ahrq.gov/patient-safety/resources/
and develop appropriate dissemination plans, if the advances/vol4/planning.html
research is determined to have “real-world” impact

Dissemination Planning Tool

Dissemination, scale-up, and sustainability

Weblink

Description

Name

Category
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the “push” for implementation science where researchers are trained to develop the evidence for implementation and skills in evaluation. Evaluation skill building
should take into account the principles of realist evaluation, a mixed-methods approach that takes into account
multiple contextual variables [169]. There is a significant
number of implementation science training opportunities across countries [160, 170, 171], though few have an
explicit focus on many of the issues we have highlighted
(e.g., health equity, designing for dissemination, sustainability, policy implementation). There has also been inadequate training and too little emphasis on the “pull” for
implementation science (e.g., training the practitioners/
implementers) [170, 172]. This emphasis on “pull” should
embrace the audience differences in Table 5. There is even
less evidence on who and how to conduct capacity building, especially in low-resource settings [171, 173].
There are also macro-level actions that would facilitate
a broader and more robust evidence base. For example,
funders and guideline developers should adopt a more
comprehensive definition of evidence, addressing many
of the recommendations outlined in Table 4 and above.
This could include an alternative or addition to GRADE,
incorporating methods of appraising research that does
not automatically elevate RCTs (particularly when
answering policy-related research questions). Similarly, it
is helpful for study sections to be oriented to a wide array
of evidence, particularly type 3 evidence. This will require
some learning as well as some unlearning—as an example, we need to broaden our understanding of contextual
mediators and moderators of implementation, which are
likely to vary from those identified in highly controlled
experiments.

Conclusion
Over the past few decades, there has been substantial
progress in defining evidence for clinical and public
health practice, identifying evidence gaps, and making initial progress in filling certain gaps. Yet to solve
the health challenges facing society, we need new and
expanded thinking about evidence and commitment to
context-based decision-making. This process begins
with evidence—a foundation of implementation science. By critically examining and broadening current
concepts of evidence, implementation science can better fulfill its vision of providing an explicit response to
decades of scientific progress that has not translated
into equitable and sustained improvements in population health [92].
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